Inhibikase Therapeutics, Inc.
Public company- Headquarters
- WILMINGTON, Delaware
- Industry
- Biotechnology
- Ticker
- IKT
- CIK
- 0001750149
WARN notices since 2024
0
None on record
Workers affected since 2024
0
Across 0 notices
Executive changes, last 12 months
2
1 appointment, 1 departure
Last event
Oct 20, 2026
Executive departuredirector departs: Dennis Berman
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| directorDennis Berman | Oct 20, 2026 | Departed |
| Class III directorScott Wasserman | Oct 20, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- ANAVEX LIFE SCIENCES CORP.
CEO appointed: Terrie Kellmeyer, Ph.D.
- RECURSION PHARMACEUTICALS, INC.
Chair of the Board appointed: Fred Hassan
- Vir Biotechnology, Inc.
Class III director appointed: Suzanne Topalian, M.D.
- AMGEN INC
director appointed: David W. Gibbs
No events of this type on record.
Show all eventsLast verified Nov 9, 2026